LINGO1-targeted antibody-drug conjugates improve efficacy and tolerability of antineoplastic therapies in Ewing sarcoma models. [PDF]
Zhu Z +5 more
europepmc +1 more source
The Next Wave of Immunotherapy: A Critical Review of Nanotechnology Strategies for Immune Checkpoint Blockade. [PDF]
Almuqbil RM.
europepmc +1 more source
Harnessing Fc-Directed Bioconjugation for the Synthesis of Site-Specifically Modified Radioimmunoconjugates. [PDF]
Grimaldi C +8 more
europepmc +1 more source
Complement in HER2-Positive Breast Cancer: A Conditionally Protective Mechanism Under Attack. [PDF]
Petkova D +6 more
europepmc +1 more source
Precision Labeling of Native Antibodies with Lock Coupling. [PDF]
Liu Y +8 more
europepmc +1 more source
BioDRUMs: An Open-Source Python Pipeline for Automated Mean Drug-to-Antibody Ratio and Biologics Structural Integrity Analysis from High-Resolution Mass Spectrometry Data. [PDF]
Di Ianni A +4 more
europepmc +1 more source
In vitro evaluation of anti-HIV radioimmunoconjugates labeled with astatine-211, thorium-227 and actinium-225. [PDF]
Kuhlmann AS +10 more
europepmc +1 more source
Refractory Diabetic Ketoacidosis Associated with Enfortumab Vedotin: A Pharmacokinetic-Based Management Approach. [PDF]
Patel SK +3 more
europepmc +1 more source
Targeted <sup>89</sup>Zr-Labeled metallofluorocarbon nanoemulsion for carcinoembryonic antigen PET. [PDF]
Tang K +6 more
europepmc +1 more source
Acquired bone marrow aplasia and long-lasting complete remission with Loncastuximab Tesirine in a patient with transformed marginal zone lymphoma: a case report. [PDF]
Esposito L +3 more
europepmc +1 more source

